BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ovsyannikova IG, Dhiman N, Jacobson RM, Poland GA. Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines. Expert Rev Vaccines 2006;5:33-43. [PMID: 16451106 DOI: 10.1586/14760584.5.1.33] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Zimmermann P, Curtis N. The influence of probiotics on vaccine responses – A systematic review. Vaccine 2018;36:207-13. [DOI: 10.1016/j.vaccine.2017.08.069] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
2 Julg B, Alter G. Lymph node fibrosis: a structural barrier to unleashing effective vaccine immunity. J Clin Invest 2018;128:2743-5. [PMID: 29781815 DOI: 10.1172/JCI121053] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Gröndahl-Yli-Hannuksela K, Vahlberg T, Ilonen J, Mertsola J, He Q. Polymorphism of IL-10 gene promoter region: association with T cell proliferative responses after acellular pertussis vaccination in adults. Immunogenetics 2016;68:733-41. [PMID: 27282930 DOI: 10.1007/s00251-016-0923-0] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
4 Stern LJ, Calvo-Calle JM. HLA-DR: molecular insights and vaccine design. Curr Pharm Des 2009;15:3249-61. [PMID: 19860674 DOI: 10.2174/138161209789105171] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
5 Yao Y, Yang H, Shi L, Liu S, Li C, Chen J, Zhou Z, Sun M, Shi L. HLA Class II Genes HLA-DRB1, HLA-DPB1, and HLA-DQB1 Are Associated With the Antibody Response to Inactivated Japanese Encephalitis Vaccine. Front Immunol 2019;10:428. [PMID: 30906300 DOI: 10.3389/fimmu.2019.00428] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Georgopoulos AP, James LM, Mahan MY, Joseph J, Georgopoulos A, Engdahl BE. Reduced Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI). EBioMedicine 2016;3:79-85. [PMID: 26870819 DOI: 10.1016/j.ebiom.2015.11.037] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
7 Gröndahl-Yli-Hannuksela K, Vuononvirta J, Barkoff AM, Viander M, Van Der Meeren O, Mertsola J, He Q. Gene polymorphism in toll-like receptor 4: effect on antibody production and persistence after acellular pertussis vaccination during adolescence. J Infect Dis 2012;205:1214-9. [PMID: 22383676 DOI: 10.1093/infdis/jis182] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
8 Sirugo G, Hennig BJ, Adeyemo AA, Matimba A, Newport MJ, Ibrahim ME, Ryckman KK, Tacconelli A, Mariani-Costantini R, Novelli G, Soodyall H, Rotimi CN, Ramesar RS, Tishkoff SA, Williams SM. Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. Hum Genet 2008;123:557-98. [PMID: 18512079 DOI: 10.1007/s00439-008-0511-y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
9 Zimmermann P, Curtis N. The influence of the intestinal microbiome on vaccine responses. Vaccine 2018;36:4433-9. [DOI: 10.1016/j.vaccine.2018.04.066] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 12.0] [Reference Citation Analysis]
10 Salas D, Kwikkers KL, Zabaleta N, Bazo A, Petry H, van Deventer SJ, Aseguinolaza GG, Ferreira V. Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates. Blood Adv 2019;3:2632-41. [PMID: 31501158 DOI: 10.1182/bloodadvances.2019000380] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
11 Poland GA, Whitaker JA, Poland CM, Ovsyannikova IG, Kennedy RB. Vaccinology in the third millennium: scientific and social challenges. Curr Opin Virol 2016;17:116-25. [PMID: 27039875 DOI: 10.1016/j.coviro.2016.03.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
12 Tanu AR, Ashraf MA, Hossain MF, Ismail M, Shekhar HU. Identification and validation of T-cell epitopes in outer membrane protein (OMP) of Salmonella typhi. Bioinformation 2014;10:480-6. [PMID: 25258481 DOI: 10.6026/97320630010480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Dendrou CA, Petersen J, Rossjohn J, Fugger L. HLA variation and disease. Nat Rev Immunol 2018;18:325-39. [PMID: 29292391 DOI: 10.1038/nri.2017.143] [Cited by in Crossref: 196] [Cited by in F6Publishing: 172] [Article Influence: 49.0] [Reference Citation Analysis]
14 Thomas C, Moridani M. Interindividual variations in the efficacy and toxicity of vaccines. Toxicology 2010;278:204-10. [PMID: 19837123 DOI: 10.1016/j.tox.2009.10.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
15 Parks S, Avramopoulos D, Mulle J, Mcgrath J, Wang R, Goes FS, Conneely K, Ruczinski I, Yolken R, Pulver AE, Pearce BD. HLA typing using genome wide data reveals susceptibility types for infections in a psychiatric disease enriched sample. Brain, Behavior, and Immunity 2018;70:203-13. [DOI: 10.1016/j.bbi.2018.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
16 Kimman TG, Vandebriel RJ, Hoebee B. Genetic variation in the response to vaccination. Community Genet 2007;10:201-17. [PMID: 17895626 DOI: 10.1159/000106559] [Cited by in Crossref: 28] [Cited by in F6Publishing: 45] [Article Influence: 1.9] [Reference Citation Analysis]
17 Sari S, Dalgic B, Basturk B, Gonen S, Soylemezoglu O. Immunogenicity of hepatitis A vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr. 2011;53:532-535. [PMID: 21587080 DOI: 10.1097/mpg.0b013e318223b3ed] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
18 Driciru E, Koopman JPR, Cose S, Siddiqui AA, Yazdanbakhsh M, Elliott AM, Roestenberg M. Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings. Front Immunol 2021;12:635985. [PMID: 33746974 DOI: 10.3389/fimmu.2021.635985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zimmermann P, Curtis N. The influence of BCG on vaccine responses – a systematic review. Expert Review of Vaccines 2018;17:547-54. [DOI: 10.1080/14760584.2018.1483727] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
20 Falola MI, Wiener HW, Wineinger NE, Cutter GR, Kimberly RP, Edberg JC, Arnett DK, Kaslow RA, Tang J, Shrestha S. Genomic copy number variants: evidence for association with antibody response to anthrax vaccine adsorbed. PLoS One 2013;8:e64813. [PMID: 23741398 DOI: 10.1371/journal.pone.0064813] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
21 Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther. 2007;82:653-664. [PMID: 17971814 DOI: 10.1038/sj.clpt.6100415] [Cited by in Crossref: 136] [Cited by in F6Publishing: 131] [Article Influence: 9.1] [Reference Citation Analysis]
22 Poland GA, Ovsyannikova IG, Jacobson RM. Vaccine immunogenetics: bedside to bench to population. Vaccine 2008;26:6183-8. [PMID: 18598732 DOI: 10.1016/j.vaccine.2008.06.057] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
23 Muyanja E, Ssemaganda A, Ngauv P, Cubas R, Perrin H, Srinivasan D, Canderan G, Lawson B, Kopycinski J, Graham AS, Rowe DK, Smith MJ, Isern S, Michael S, Silvestri G, Vanderford TH, Castro E, Pantaleo G, Singer J, Gillmour J, Kiwanuka N, Nanvubya A, Schmidt C, Birungi J, Cox J, Haddad EK, Kaleebu P, Fast P, Sekaly RP, Trautmann L, Gaucher D. Immune activation alters cellular and humoral responses to yellow fever 17D vaccine. J Clin Invest 2014;124:3147-58. [PMID: 24911151 DOI: 10.1172/JCI75429] [Cited by in Crossref: 109] [Cited by in F6Publishing: 81] [Article Influence: 13.6] [Reference Citation Analysis]
24 Thompson MK, Fridy PC, Keegan S, Chait BT, Fenyö D, Rout MP. Optimizing selection of large animals for antibody production by screening immune response to standard vaccines. J Immunol Methods 2016;430:56-60. [PMID: 26775851 DOI: 10.1016/j.jim.2016.01.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ovsyannikova IG, Jacobson RM, Dhiman N, Vierkant RA, Pankratz VS, Poland GA. Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics 2008;121:e1091-9. [PMID: 18450852 DOI: 10.1542/peds.2007-1575] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]